FDA’s Wayback Machine: Clinical Investigator Disqualifications Could Trigger Wide-Ranging Audits
This article was originally published in The Pink Sheet Daily
Executive Summary
Any clinical trial that an FDA-disqualified investigator was involved in may be subject to scrutiny, the agency says in explaining a final rule.